Kawashima M, Watanabe D, Fujio K, Komazaki H, et al. A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis. J Dermatol 2023;50:311-318.
PMID: 36353762